Download Citation
Article Source:
Cost-effectiveness of midomafetamine-assisted therapy (MDMA-AT) in chronic and treatment-resistant post-traumatic stress disorder of moderate or higher severity: A health-economic model
Stanicic F,
Zah V,
Grbic D,
De Angelo D
(2024)
Cost-effectiveness of midomafetamine-assisted therapy (MDMA-AT) in chronic and treatment-resistant post-traumatic stress disorder of moderate or higher severity: A health-economic model.
PLOS ONE 19(11): e0313569.
https://doi.org/10.1371/journal.pone.0313569